BIIB. The New England Journal of Medicine Publishes Pivotal Data Demonstrating Efficacy and Safety of Oral BG-12 (Dimethyl Fumarate) in Multiple Sclerosis Results of Phase 3 DEFINE and CONFIRM Studies Support Dimethyl Fumarate’s Potential as a Strong Option for MS Treatment http://finance.yahoo.com/news/england-journal-medicine-publishes-pivotal-210000550.html